ABBOTT LABORATORIES — Director's Dealing 2018

Nov 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-11-02

Reporting Person: Watkin Jared (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-02	Common shares without par value	M	65000	$38.40	Acquired	128640	Direct
2018-11-02	Common shares without par value	S	65000	$71	Disposed	63640	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-02	Option (right to buy)	$38.40	M	65000	Disposed	2026-02-18	Common shares (65000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	521	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 2, 2018.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

F3: Options for these shares became exercisable on 02/19/2017 and 02/19/2018.